Focused Wealth Management’s BiondVax Pharmaceuticals Ltd. BVXVW Stock Holding History

Focused Wealth Management’s Portfolio BVXVW Stock Details BVXVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,107	Closed	-$3K	–	866
2020 Q1	$3K	Buy	+8,107	New	+$23K	﹤0.01%	599

Focused Wealth Management's BVXVW Position: Q2 2020 in Review

Focused Wealth Management sold out of BiondVax Pharmaceuticals Ltd. (BVXVW) in Q2 2020, closing a stake of 8,107 shares — an estimated $3K sold.

Focused Wealth Management first reported a position in BVXVW in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 0 funds tracked by Wall St. Rank hold BVXVW as of Q2 2020.

Focused Wealth Management reported no remaining BiondVax Pharmaceuticals Ltd. position as of Q2 2020 after selling out during the quarter.
Focused Wealth Management sold 8,107 BiondVax Pharmaceuticals Ltd. shares in Q2 2020, an estimated $3K.
Focused Wealth Management first reported a position in BiondVax Pharmaceuticals Ltd. in Q1 2020 and held it in 1 quarter.
Focused Wealth Management's BiondVax Pharmaceuticals Ltd. position peaked at $3K in Q1 2020.
0 funds tracked by Wall St. Rank held BiondVax Pharmaceuticals Ltd. as of Q2 2020.

Based on Focused Wealth Management's 13F filing for Q2 2020, filed 24 Jul 2020.